Peer-influenced content. Sources you trust. No registration required. This is HCN.

Trending Topics:
DIET & NUTRITION PATIENT EDUCATION OBESITY/WEIGHT MANAGEMENT EXERCISE/TRAINING LEGAL MATTERS GUIDELINES/RECOMMENDATIONS

Articles related to DRUG SAFETY & INTERACTIONS

Epoch Health

Common Diabetes Drug Blocks Benefits of Exercise

“If you exercise and take metformin and your blood glucose does not go down, that’s a problem. People taking metformin also didn’t gain fitness. That means their physical function isn’t getting better, and that could have long-term health risk.” – Steven Malin, Lead Author

Endocrinology & Diabetes Nursing January 29th 2026

Tags: DIABETES EDUCATION DRUG SAFETY & INTERACTIONS EXERCISE/TRAINING HEALTH OUTCOMES TYPE 2 DIABETES

Verywell Health

What Happens to Your Blood Pressure When You Take Magnesium and Fish Oil Together?

Even small reductions in blood pressure can add up to meaningful heart health benefits.

Ambulatory Care Nursing January 29th 2026

Tags: DRUG SAFETY & INTERACTIONS HYPERTENSION/BLOOD PRESSURE PATIENT EDUCATION VITAMINS/SUPPLEMENTS

Conexiant

FDA Drops Warning From GLP-1 RAs

The FDA concluded that GLP-1 RA medications are not associated with suicidal ideation or behavior and is requesting corresponding updates to product labeling.

Endocrinology, Diabetes, Metabolism January 27th 2026

Tags: DRUG SAFETY & INTERACTIONS FDA GLP-1s GUIDELINES/RECOMMENDATIONS OBESITY/WEIGHT MANAGEMENT

Epilepsy Currents

Lamotrigine in Epilepsy: Safe for the Heart after All?

Lamotrigine was not associated with an increased risk of ventricular arrhythmia and sudden cardiac arrest compared with levetiracetam, including among those with underlying heart disease.

Cardiology January 22nd 2026

Tags: ANTISEIZURE MEDICATIONS CARDIOVASCULAR RISK DRUG SAFETY & INTERACTIONS EPILEPSY/SEIZURES

Psychiatrist.com

MAOI Antidepressants: A History Being Rewritten

The historical use of classic monoamine oxidase inhibitors (MAOIs) is overviewed, with consideration given to their efficacy and safety before discussing the importance of reassessing their place in current treatment algorithms.

Psychiatry January 21st 2026

Tags: ADVERSE EVENTS ANTIDEPRESSANTS DEPRESSION DRUG SAFETY & INTERACTIONS GUIDELINES/RECOMMENDATIONS PSYCHOPHARMACOLOGY

Annals of Internal Medicine

Risk for Cancer with Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists

GLP-1RAs may have little or no effect on risk for obesity-related cancers. Longer-term studies are needed to clarify potential risks or benefits.

Oncology, Medical January 20th 2026

Tags: CANCER RISK DRUG SAFETY & INTERACTIONS GLP-1s OBESITY/WEIGHT MANAGEMENT

Topics

Sources

American Journal of Clinical Pathology (AJCP)
American Nurse Journal (ANJ)
Anesthesiology News
Annals of Internal Medicine
British Medical Journal (The BMJ)
Cancer Therapy Advisor
Cardiology Advisor
Cleveland Clinic Journal of Medicine (CCJM)
Clinical Advisor
Conexiant
Consultant360
Cureus
Dermatology Advisor
Endocrinology Advisor
Gastroenterology Advisor
GoodRx for Healthcare Professionals
Healthgrades for Professionals
Hematology Advisor
JNP: The Journal for Nurse Practitioners
Journal of Invasive Cardiology (JIC)
Journal of the American College of Cardiology (JACC)
Journal of the National Cancer Institute (JNCI)
Mayo Clinic
MD Newsline
MDLinx
MedCentral
Medical News Today (MNT)
Medical Professionals Reference (MPR)
Neurology Advisor
Oncology News Central (ONC)
Ophthalmology Advisor
Pharmacy Practice News
Physician’s Weekly
POCN
Practical Neurology
Psychiatrist.com
Psychiatry Advisor
ReachMD
Renal & Urology News
The American Journal of Nursing (AJN)
UCLA Health
WebMD
Women’s Healthcare
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form